These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

494 related articles for article (PubMed ID: 27849377)

  • 1. IN PATIENTS WITH SUBCLINICAL HYPOTHYROIDISM WHILE IN THERAPY WITH TABLET L-T4, THE LIQUID L-T4 FORMULATION IS MORE EFFECTIVE IN RESTORING EUTHYROIDISM.
    Fallahi P; Ferrari SM; Antonelli A
    Endocr Pract; 2017 Feb; 23(2):170-174. PubMed ID: 27849377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral L-thyroxine liquid versus tablet in patients with hypothyroidism without malabsorption: a prospective study.
    Fallahi P; Ferrari SM; Antonelli A
    Endocrine; 2016 Jun; 52(3):597-601. PubMed ID: 26721663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Shift from Levothyroxine Tablets to Liquid Formulation at Breakfast Improves Quality of Life of Hypothyroid Patients.
    Guglielmi R; Grimaldi F; Negro R; Frasoldati A; Misischi I; Graziano F; Cipri C; Guastamacchia E; Triggiani V; Papini E
    Endocr Metab Immune Disord Drug Targets; 2018; 18(3):235-240. PubMed ID: 29376496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reversible normalisation of serum TSH levels in patients with autoimmune atrophic gastritis who received L-T4 in tablet form after switching to an oral liquid formulation: a case series.
    Fallahi P; Ferrari SM; Ruffilli I; Antonelli A
    BMC Gastroenterol; 2016 Feb; 16():22. PubMed ID: 26965518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Stability of TSH, and Thyroid Hormones, in Patients Treated With Tablet, or Liquid Levo-Thyroxine.
    Antonelli A; Elia G; Ragusa F; Paparo SR; Cavallini G; Benvenga S; Ferrari SM; Fallahi P
    Front Endocrinol (Lausanne); 2021; 12():633587. PubMed ID: 33790863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TSH Normalization in Bariatric Surgery Patients After the Switch from L-Thyroxine in Tablet to an Oral Liquid Formulation.
    Fallahi P; Ferrari SM; Camastra S; Politti U; Ruffilli I; Vita R; Navarra G; Benvenga S; Antonelli A
    Obes Surg; 2017 Jan; 27(1):78-82. PubMed ID: 27272506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advancements in the treatment of hypothyroidism with L-T4 liquid formulation or soft gel capsule: an update.
    Fallahi P; Ferrari SM; Ruffilli I; Ragusa F; Biricotti M; Materazzi G; Miccoli P; Antonelli A
    Expert Opin Drug Deliv; 2017 May; 14(5):647-655. PubMed ID: 27552635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liquid L-T4 therapy in hypothyroid patients with gastric diseases, an observational study.
    Fallahi P; Ragusa F; Patrizio A; Mazzi V; Botrini C; Elia G; Balestri E; Barozzi E; Rugani L; Palmisano E; Cosenza MC; Varricchi G; Ulisse S; Benvenga S; Ferrari SM; Antonelli A
    Front Endocrinol (Lausanne); 2024; 15():1386629. PubMed ID: 39027476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tablet and oral liquid L-thyroxine formulation in the treatment of naïve hypothyroid patients with Helicobacter pylori infection.
    Ribichini D; Fiorini G; Repaci A; Castelli V; Gatta L; Vaira D; Pasquali R
    Endocrine; 2017 Sep; 57(3):394-401. PubMed ID: 27848196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In thyroxine-replaced hypothyroid postmenopausal women under simultaneous calcium supplementation, switch to oral liquid or softgel capsule L-thyroxine ensures lower serum TSH levels and favorable effects on blood pressure, total cholesterolemia and glycemia.
    Morini E; Catalano A; Lasco A; Morabito N; Benvenga S
    Endocrine; 2019 Sep; 65(3):569-579. PubMed ID: 30919287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnosis and treatment of hypothyroidism in TSH deficiency compared to primary thyroid disease: pituitary patients are at risk of under-replacement with levothyroxine.
    Koulouri O; Auldin MA; Agarwal R; Kieffer V; Robertson C; Falconer Smith J; Levy MJ; Howlett TA
    Clin Endocrinol (Oxf); 2011 Jun; 74(6):744-9. PubMed ID: 21521256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-inferiority of liquid thyroxine in comparison to tablets formulation in the treatment of children with congenital hypothyroidism.
    Tzifi F; Iliadi A; Voutetakis A; Platis D; Girginoudis P; Kanaka-Gantenbein C
    J Pediatr Endocrinol Metab; 2022 Feb; 35(2):239-247. PubMed ID: 34653328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TSH evaluation in hypothyroid patients assuming liquid levothyroxine at breakfast or 30 min before breakfast.
    Pirola I; Gandossi E; Brancato D; Marini F; Cristiano A; Delbarba A; Agosti B; Castellano M; Cappelli C
    J Endocrinol Invest; 2018 Nov; 41(11):1301-1306. PubMed ID: 29582344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Levothyroxine therapy and serum free thyroxine and free triiodothyronine concentrations.
    Woeber KA
    J Endocrinol Invest; 2002 Feb; 25(2):106-9. PubMed ID: 11929079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment pattern and frequency of serum TSH measurement in users of different levothyroxine formulations: a population-based study during the years 2009-2015.
    Ferrara R; Ientile V; Arcoraci V; Ferrajolo C; Piccinni C; Fontana A; Benvenga S; Trifirò G
    Endocrine; 2017 Oct; 58(1):143-152. PubMed ID: 28155170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral L-thyroxine liquid versus tablet in patients submitted to total thyroidectomy for thyroid cancer (without malabsorption): A prospective study.
    Fallahi P; Ferrari SM; Materazzi G; Ragusa F; Ruffilli I; Patrizio A; Miccoli P; Antonelli A
    Laryngoscope Investig Otolaryngol; 2018 Oct; 3(5):405-408. PubMed ID: 30410995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. No role for tri-iodothyronine (T3) testing in the assessment of levothyroxine (T4) over-replacement in hypothyroid patients.
    Livingston M; Birch K; Guy M; Kane J; Heald AH
    Br J Biomed Sci; 2015; 72(4):160-3. PubMed ID: 26738396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of increased thyroxine dosage pre-conception on thyroid function during early pregnancy.
    Rotondi M; Mazziotti G; Sorvillo F; Piscopo M; Cioffi M; Amato G; Carella C
    Eur J Endocrinol; 2004 Dec; 151(6):695-700. PubMed ID: 15588235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liquid L-thyroxine versus tablet L-thyroxine in patients on L- thyroxine replacement or suppressive therapy: a meta-analysis.
    Laurent I; Tang S; Astère M; Wang KR; Deng S; Xiao L; Li QF
    Endocrine; 2018 Jul; 61(1):28-35. PubMed ID: 29572710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lactose intolerance and levothyroxine malabsorption: a review of the literature and report of a series of patients treated with liquid L-T4 without lactose.
    Ferrari SM; Patrizio A; Mazzi V; Ragusa F; Botrini C; Elia G; Balestri E; Barozzi E; Rugani L; Bracchitta F; Stoppini G; Frenzilli G; Baldini E; Virili C; Benvenga S; Fallahi P; Antonelli A
    Front Endocrinol (Lausanne); 2024; 15():1386510. PubMed ID: 38665263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.